stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Revenue growth
iRhythm Holdings, Inc.'s revenue growth over the twelve months to 30 September 2026 was 21.6%, down 4.7 percentage points from fiscal 2025 (26.2%). Over the past ten years it has ranged from 19.9% (fiscal 2023) to 77.3% (fiscal 2016); the current reading is higher than 45% of that period. That is above the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 26.2% | 6.11 |
| FY2024 | 20.1% | 0.23 |
| FY2023 | 19.9% | (7.39) |
| FY2022 | 27.3% | 5.55 |
| FY2021 | 21.7% | (1.85) |
| FY2020 | 23.6% | (22.09) |
| FY2019 | 45.7% | (2.89) |
| FY2018 | 48.6% | (6.15) |
| FY2017 | 54.7% | (22.57) |
| FY2016 | 77.3% | 11.12 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 14.9% | (5.20) |
| Jun 2026 | 20.1% | (5.58) |
| Mar 2026 | 25.7% | (1.46) |
| Dec 2025 | 27.1% | (3.62) |
| 40 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| TMDX TransMedics Group, Inc. compare | 28.5% |
| AXGN AxoGen, Inc. compare | 24.3% |
| IRTC iRhythm Holdings, Inc. | 21.6% |
| LIVN LivaNova PLC compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 8.62% |
| HAE Haemonetics Corporation compare | 4.11% |
| ITGR Integer Holdings Corporation compare | −0.31% |
| NEOG Neogen Corporation compare | −0.33% |
| TXG 10x Genomics compare | −4.28% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on IRTC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement